349 related articles for article (PubMed ID: 29948644)
1. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.
Hefazi M; Litzow MR
Curr Hematol Malig Rep; 2018 Aug; 13(4):265-274. PubMed ID: 29948644
[TBL] [Abstract][Full Text] [Related]
2. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
[TBL] [Abstract][Full Text] [Related]
3. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic Value of Recurrent Molecular Genetics and Epigenetics Abnormity in T Lymphoblastic Lymphoma / Leukemia -Review].
Guan W; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):587-591. PubMed ID: 28446316
[TBL] [Abstract][Full Text] [Related]
5. Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.
Valliyammai N; Nancy NK; Sagar TG; Rajkumar T
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e1-e8. PubMed ID: 29200162
[TBL] [Abstract][Full Text] [Related]
6. Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
Jenkinson S; Koo K; Mansour MR; Goulden N; Vora A; Mitchell C; Wade R; Richards S; Hancock J; Moorman AV; Linch DC; Gale RE
Leukemia; 2013 Jan; 27(1):41-7. PubMed ID: 22814294
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of
Yuan Y; Li J; Xue TL; Hu HR; Lin W; Liu SG; Zhang RD; Zheng HY; Gao C
Leuk Lymphoma; 2022 Jul; 63(7):1624-1633. PubMed ID: 35129045
[No Abstract] [Full Text] [Related]
8. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
Mansour MR; Sulis ML; Duke V; Foroni L; Jenkinson S; Koo K; Allen CG; Gale RE; Buck G; Richards S; Paietta E; Rowe JM; Tallman MS; Goldstone AH; Ferrando AA; Linch DC
J Clin Oncol; 2009 Sep; 27(26):4352-6. PubMed ID: 19635999
[TBL] [Abstract][Full Text] [Related]
9. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
[TBL] [Abstract][Full Text] [Related]
10. [The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients].
Fang QY; Hao QS; Gong XY; Wang J; Li QH; Yuan T; Tian Z; Liu KQ; Li Y; Liu YT; Gong BF; Wang Y; Wei H; Zhou CL; Lin D; Liu BC; Wei SN; Zhang GJ; Wang JX; Mi YC
Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):432-435. PubMed ID: 34218589
[No Abstract] [Full Text] [Related]
11. Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols.
Fogelstrand L; Staffas A; Wasslavik C; Sjögren H; Söderhäll S; Frost BM; Forestier E; Degerman S; Behrendtz M; Heldrup J; Karrman K; Johansson B; Heyman M; Abrahamsson J; Palmqvist L
Pediatr Blood Cancer; 2014 Mar; 61(3):424-30. PubMed ID: 24424791
[TBL] [Abstract][Full Text] [Related]
12. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
Callens C; Baleydier F; Lengline E; Ben Abdelali R; Petit A; Villarese P; Cieslak A; Minard-Colin V; Rullier A; Moreau A; Baruchel A; Schmitt C; Asnafi V; Bertrand Y; Macintyre E
J Clin Oncol; 2012 Jun; 30(16):1966-73. PubMed ID: 22547598
[TBL] [Abstract][Full Text] [Related]
14. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
[TBL] [Abstract][Full Text] [Related]
15. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL.
Erbilgin Y; Sayitoglu M; Hatirnaz O; Dogru O; Akcay A; Tuysuz G; Celkan T; Aydogan G; Salcioglu Z; Timur C; Yuksel-Soycan L; Ure U; Anak S; Agaoglu L; Devecioglu O; Yildiz I; Ozbek U
Dis Markers; 2010; 28(6):353-60. PubMed ID: 20683149
[TBL] [Abstract][Full Text] [Related]
17. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
Bandapalli OR; Zimmermann M; Kox C; Stanulla M; Schrappe M; Ludwig WD; Koehler R; Muckenthaler MU; Kulozik AE
Haematologica; 2013 Jun; 98(6):928-36. PubMed ID: 23349303
[TBL] [Abstract][Full Text] [Related]
18. Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.
Chang YH; Yu CH; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Chang HH; Lin DT; Lin SW; Chen HY; Yang YL
Sci Rep; 2021 Jan; 11(1):769. PubMed ID: 33436855
[TBL] [Abstract][Full Text] [Related]
19. The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.
Kox C; Zimmermann M; Stanulla M; Leible S; Schrappe M; Ludwig WD; Koehler R; Tolle G; Bandapalli OR; Breit S; Muckenthaler MU; Kulozik AE
Leukemia; 2010 Dec; 24(12):2005-13. PubMed ID: 20944675
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].
Wu CY; Li YL; Dong XY; Yang SW; Shang BJ; Zhang L; Cheng W; Zhang L; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1910-1917. PubMed ID: 35768390
[No Abstract] [Full Text] [Related]
[Next] [New Search]